L&K Biomed Ltd. (KOSDAQ:156100)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Manufacture and Sale of Medical Devices	38.92B	36.09B	29.90B	19.77B	15.37B
Total	38.92B	36.09B	29.90B	19.77B	15.37B

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
USA	26.18B	24.59B	21.82B	-	10.29B
South Korea	1.07B	1.48B	2.44B	659.84M	2.72B
Thailand	5.55B	4.12B	2.49B	-	895.19M
Other	6.12B	5.89B	3.15B	-	1.46B
Overseas	-	-	-	19.11B	-
Total	38.92B	36.09B	29.90B	19.77B	15.37B

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 13, 2026

Data Sources Report a data error